Gregory W. Schafer, Chief Operating Officer at ADURO BIOTECH, INC. (ADRO), sold 26,470 shares at $27.51 ($745K) on 2015-11-16, disclosed to the SEC on 2015-11-18.
Scheduled sale ($745k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.50 | 1,470 | $40K | 5.4% |
| 2 | $27.51 | 9,222 | $254K | 34.0% |
| 3 | $28.41 | 600 | $17K | 2.3% |
| 4 | $27.87 | 2,608 | $73K | 9.8% |
| 5 | $28.75 | 12,570 | $361K | 48.5% |
| Total | $28.15 avg | 26,470 |
| $745K |
| 100% |
| Filing → |
| ADRO | SELL | 2017-11-08 | $159K | — | Filing → |
| ADRO | SELL | 2017-10-04 | $215K | — | Filing → |
| ADRO | SELL | 2017-09-14 | $53K | — | Filing → |